Trial Profile
Pharmacogenetics study of telmisartan in hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Essential hypertension
- Focus Pharmacogenomic; Pharmacokinetics
- 18 Jan 2013 New trial record